AboBoNT-A + OnaBoNT-A
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Upper Limb Spasticity
Conditions
Upper Limb Spasticity
Trial Timeline
Jun 23, 2021 → Aug 26, 2025
NCT ID
NCT04936542About AboBoNT-A + OnaBoNT-A
AboBoNT-A + OnaBoNT-A is a approved stage product being developed by Ipsen for Upper Limb Spasticity. The current trial status is completed. This product is registered under clinical trial identifier NCT04936542. Target conditions include Upper Limb Spasticity.
What happened to similar drugs?
5 of 14 similar drugs in Upper Limb Spasticity were approved
Approved (5) Terminated (1) Active (9)
Hype Score Breakdown
Clinical
20
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04936542 | Approved | Completed |
Competing Products
20 competing products in Upper Limb Spasticity